Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN16597283Phase 4Completed
Phase 4, randomised, open-label trial in bartonellosis and Carrion's disease comparing Rifampin with Azithromycin (2 arms). Primary endpoints: Time to resolution of verrucous lesions and Time to resolution of Bartonella bacteremia. Started Jun 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN16597283.